Document is current
Any future updates will be listed below
-
Authors
Blumenberg, Viktoria
Maus, Marcela V. http://orcid.org/0000-0002-7578-0393
- License Information
-
More Information
Article History
First Online: 30 August 2024
Competing interests
: V.B. receives research support from BMS, Kite Pharma, Novartis, Roche and Takeda and has received consulting fees from Kite Pharma, Novartis and Roche. M.V.M. is an inventor on patents related to adoptive cell therapies, held by Massachusetts General Hospital and the University of Pennsylvania (some licensed to Novartis); holds equity in Cargo, Model T bio, Oncternal and Neximmune; serves on the Board of Directors of 2Seventy Bio; and has served as a consultant for multiple companies involved in cell therapies. M.V.M.’s interests were reviewed and are managed by Massachusetts General Hospital, and Mass General Brigham in accordance with their conflict-of-interest policies.
